Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 767892, 7 pages
Research Article

GP's Adherence to Guidelines for Cardiovascular Disease among Elderly: A Quality Development Study

1Division of Family Medicine, Department of Clinical Sciences in Malmö, Skåne University Hospital, Lund University, 205 02 Malmö, Sweden
2Tåbelund Primary Health Care Centre, Solv. 33, 241 31 Eslöv, Sweden
3RSKC Competence Centre for Clinical Research, Skåne University Hospital, 22 185 Lund, Sweden

Received 19 October 2011; Accepted 27 December 2011

Academic Editors: C. Capurso and J. C. Geller

Copyright © 2012 Sara Modig et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. Evidence-based guidelines should in most cases be followed also in the treatment of elderly. Older people are often suboptimally treated with the recommended drugs. Objectives. To describe how well general practitioners adhere to current guidelines in the treatment of elderly with cardiovascular disease and evaluate local education as a tool for improvement. Method. Data was collected from the medical records of patients aged ≥65, who visited a primary health care center in Sweden 2006 and had one or more of the following diagnoses: hypertension, ischemic heart disease, heart failure, chronic atrial fibrillation, or prior stroke. Local education was organized and included feed-back to the patient’s doctor and discussion about regional guidelines. Repeated measurements were performed in 2008. Results and Conclusion. The adherence to guidelines was low. Approximately one-third of the patients with hypertension reached target blood pressure, stroke patients more often. More patients with heart failure were treated with angiotensin converting enzyme inhibitor than in other European countries, but still only 60%. Half of the patients with chronic atrial fibrillation were treated with Warfarin, although more than two-thirds had a CHADS2 score indicating the need. Educational efforts appeared to increase the adherence and hence should be encouraged.